Synthesis, biological assays and QSAR studies of N-(9-benzyl-2-phenyl-8-azapurin-6-yl)-amides as ligands for A1 adenosine receptors. 2009

Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
Dipartimento di Scienze Farmaceutiche, Università di Pisa, Pisa, Italy. igiorgi@farm.unipi.it

2-Phenyl-9-benzyl-8-azapurines, bearing at the 6 position an amido group interposed between the 8-azapurine moiety and an alkyl or a substituted phenyl group, have been synthesised and assayed as ligands for adenosine receptors. All the compounds show high affinity for the A(1) adenosine receptor, and many of them also show a good selectivity for A(1) with respect to A(2A) and A(3) adenosine receptors. Based on the quite rich library containing such compounds and relevant biological data, QSAR models, able to rationalise the results and to give a quantitative estimate of the observed trends were also developed. The obtained models can assist in the design of new compounds selectively active on A(1) adenosine receptor.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D043682 Receptor, Adenosine A1 A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of tissues including the BRAIN and DORSAL HORN NEURONS. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP. Adenosine A1 Receptors,Adenosine A1 Receptor,Receptors, Adenosine A1
D043684 Receptor, Adenosine A3 A subtype of ADENOSINE RECEPTOR that is found expressed in a variety of locations including the BRAIN and endocrine tissues. The receptor is generally considered to be coupled to the GI, INHIBITORY G-PROTEIN which causes down regulation of CYCLIC AMP. Adenosine A3 Receptors,Adenosine A3 Receptor,A3 Receptor, Adenosine,A3 Receptors, Adenosine,Receptors, Adenosine A3
D043705 Receptor, Adenosine A2A A subclass of adenosine A2 receptors found in LEUKOCYTES, the SPLEEN, the THYMUS and a variety of other tissues. It is generally considered to be a receptor for ADENOSINE that couples to the GS, STIMULATORY G-PROTEIN. Adenosine A2A Receptor,Adenosine A(2A) Receptor,Adenosine A2A Receptors,A2A Receptor, Adenosine,A2A Receptors, Adenosine,Receptors, Adenosine A2A
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D058916 Adenosine A1 Receptor Antagonists Compounds that bind to and block the stimulation of ADENOSINE A1 RECEPTORS.
D058917 Adenosine A2 Receptor Antagonists Compounds that selectively bind to and block the activation of ADENOSINE A2 RECEPTORS. Adenosine A2A Receptor Antagonists,Adenosine A2B Receptor Antagonists

Related Publications

Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
December 2001, Farmaco (Societa chimica italiana : 1989),
Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
June 1996, Farmaco (Societa chimica italiana : 1989),
Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
October 1995, Farmaco (Societa chimica italiana : 1989),
Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
January 1995, Farmaco (Societa chimica italiana : 1989),
Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
March 1994, Farmaco (Societa chimica italiana : 1989),
Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
March 1994, Farmaco (Societa chimica italiana : 1989),
Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
November 1975, Journal of medicinal chemistry,
Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
March 2002, Farmaco (Societa chimica italiana : 1989),
Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
June 2003, Farmaco (Societa chimica italiana : 1989),
Irene Giorgi, and Michele Leonardi, and Daniele Pietra, and Giuliana Biagi, and Alice Borghini, and Ilaria Massarelli, and Osele Ciampi, and Anna Maria Bianucci
December 2012, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!